Yes, it is predominantly for funding orders, however, that in itself is a sign of failure re: the ability of the last acquisition to contribute sufficient working capital to scale the business. After all, they effectively did a reverse takeover with OmniBlend, such was the scope of what they acquired relative to what they had. That was meant to be an acquisition that would provide scope to fund broader activity in the business, yet as that acquisition has underperformed by some extent, they're now tapping the market again.
Aside from that, in the AFR article, if you continue reading a little further you'll note the following: "On top of providing working capital funding to service demand, the money was also pegged for acquisition opportunities". So I wouldn't expect them to announce any acquisition up front or for a while, for that matter. However, the mere notion it is being entertained after the last acquisition has performed so poorly should be cause for concern.
- Forums
- ASX - By Stock
- Ann: Trading Halt
Yes, it is predominantly for funding orders, however, that in...
-
- There are more pages in this discussion • 445 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HLF (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.805M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
HLF (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online